Quince Therapeutics, Inc. — All Filings
402 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
3/A
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-117794 | Mar 20, 2026 | Mar 16, 2026 |
| SCHEDULE 13G | — | 0000932540-26-000004 | Mar 5, 2026 | — |
| 8-K | 8-K | 0001193125-26-047544 | Feb 12, 2026 | — |
| 8-K | 8-K | 0001193125-26-033758 | Feb 2, 2026 | Jan 30, 2026 |
| 8-K | 8-K | 0001193125-26-029524 | Jan 29, 2026 | — |
| 4 | FORM 4 | 0000912282-26-000121 | Jan 23, 2026 | — |
| 4 | FORM 4 | 0000912282-26-000120 | Jan 23, 2026 | — |
| 4 | FORM 4 | 0000912282-26-000119 | Jan 23, 2026 | — |
| 4 | FORM 4 | 0000912282-26-000089 | Jan 21, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0000912282-26-000087 | Jan 21, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0000912282-26-000085 | Jan 21, 2026 | Jan 2, 2026 |
| 4 | FORM 4 | 0000912282-26-000083 | Jan 21, 2026 | Jan 2, 2026 |
| 144 | — | 0001628280-25-059050 | Dec 29, 2025 | — |
| 4 | FORM 4 | 0000912282-25-001469 | Dec 29, 2025 | Dec 26, 2025 |
| 4 | FORM 4 | 0000912282-25-001468 | Dec 29, 2025 | Oct 23, 2024 |
| 4 | FORM 4 | 0000912282-25-001407 | Dec 12, 2025 | Dec 10, 2025 |
| 4 | FORM 4 | 0000912282-25-001370 | Dec 8, 2025 | Dec 5, 2025 |
| SCHEDULE 13G/A | — | 0001104659-25-112623 | Nov 14, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-277529 | Nov 12, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-277523 | Nov 12, 2025 | — |
| SCHEDULE 13G/A | — | 0001140361-25-039832 | Oct 30, 2025 | — |
| 8-K | 8-K | 0001193125-25-242514 | Oct 17, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-242511 | Oct 17, 2025 | — |
| 8-K | 8-K | 0001193125-25-220722 | Sep 26, 2025 | Sep 25, 2025 |
| SCHEDULE 13G | — | 0001104659-25-078682 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106535 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106536 | Aug 11, 2025 | — |
| EFFECT | — | 9999999995-25-002488 | Aug 5, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-173623 | Aug 5, 2025 | — |
| CORRESP | — | 0001193125-25-171664 | Aug 1, 2025 | — |
| UPLOAD | — | 0000000000-25-008116 | Aug 1, 2025 | — |
| S-3 | S-3 | 0001193125-25-165524 | Jul 25, 2025 | — |
| 8-K | 8-K | 0001193125-25-159886 | Jul 16, 2025 | — |
| D | — | 0001662774-25-000035 | Jul 1, 2025 | — |
| 4 | — | 0000912282-25-000697 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | — | 0000912282-25-000696 | Jun 23, 2025 | Jun 18, 2025 |
| 4 | — | 0000912282-25-000695 | Jun 23, 2025 | Jun 18, 2025 |
| 8-K | 8-K | 0001193125-25-140873 | Jun 13, 2025 | Jun 12, 2025 |
| 4 | — | 0000912282-25-000625 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000623 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000621 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000619 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000617 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000615 | Jun 6, 2025 | Jun 4, 2025 |
| 4 | — | 0000912282-25-000613 | Jun 6, 2025 | Jun 4, 2025 |
| 8-K | 8-K | 0001662774-25-000034 | Jun 5, 2025 | Jun 4, 2025 |
| 10-Q | 10-Q | 0001662774-25-000032 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0001662774-25-000031 | May 13, 2025 | — |
| SCHEDULE 13G/A | — | 0001104659-25-042498 | Apr 30, 2025 | — |
| ARS | ARS | 0001662774-25-000027 | Apr 23, 2025 | Dec 31, 2024 |